Viemed Healthcare (VMD) Net Margin (2018 - 2026)

Viemed Healthcare has reported Net Margin for 9 years, with the latest figure at 3.6% in Q1 2026.

• For the quarter ending Q1 2026, Net Margin fell 99.0% year-over-year to 3.6%; the trailing twelve-month figure through Mar 2026 stood at 5.37% (down 1.0% YoY), and the FY2025 full-year result was 5.69%, up 60.0% from the prior year.
• Net Margin for Q1 2026 stood at 3.6%, down from 7.63% in the prior quarter.
• The five-year high for Net Margin was 7.63% in Q4 2025, with the low at 2.69% in Q2 2024.
• Historically, Net Margin has averaged 5.04% across 5 years, with a median of 5.15% in 2025.
• Annual changes were most pronounced in 2022 — Net Margin plunged 629 bps — and 2023, when it jumped 296 bps.
• Viemed Healthcare's Net Margin stood at 6.5% in 2022, then grew by 5 bps to 6.85% in 2023, then gained by 6 bps to 7.29% in 2024, then rose by 5 bps to 7.63% in 2025, then slumped by 53 bps to 3.6% in 2026.
• The last three Net Margin figures came in at 3.6% (Q1 2026), 7.63% (Q4 2025), and 5.01% (Q3 2025), per Business Quant data.